The The The

The 5 ASX stocks that will likely be supported vs the 17 facing headwinds

Equity 6 minutes to read
Jessica Amir

Australian Market Strategist

Summary:  What an important time of year. Not only is it end of half year in the US and End Of Financial Year in Australia, but the index and benchmark creator, S&P Dow Jones Indices is adding and removing stocks from key ASX indices ahead of June 20. So, we are sharing the five stocks that could likely to be supported, and the 17 stocks that could face headwinds after being removed from key indices.


As the news broke late Friday afternoon, that the S&P Dow Jones Indices quarterly rebalance was announced, we were quick to Tweet it. No surprises for guessing, the benchmark ASX200 index will be welcoming 4 mostly commodity companies who have been outperforming the market, while it is booting out 4 tech companies and one investment manager who’s shares have taken a slide as we nestle into higher for longer interest rates.

It’s important to note, the S&P Dow Jones Indices reveals which stocks it will add/remove from various key indices ahead of time, so investors, ETF providers and fund managers have a head start, before the changes take effect, before Monday 20 June. This means, if a stock is added to the index, ETF providers who copycat indices will typically be forced to compulsorily buy stocks being added and sell stocks being removed from key indices.

Simultaneity, it’s already a very busy time of year; Half Year rebalancing in the US, and End of Financial Year rebalancing in Australia, takes place prior to June 30. This is typically where we see investment managers bring their asset allocations back into alignment. This might mean fund managers trim profits from stocks and sectors that have done well. And they add to positions in those stocks and sectors that have underperformed year-on-year, to ensure their funds meet their set mandates.

However now, as 5 ASX stocks will be added and 17 will ousted from key indices before June 20 2022, it’s really important to note which stocks they are, as they may face bigger swings in there prices (due to S&P Rebalancing and EOFY).


In the ASX50

  • Mineral Resources (MIN) will be ADDED.

In the ASX50

  • Block (SQ2) will be REMOVED


In the ASX100

  •  Magellan Financial Group (MFG) will be REMOVED

In the ASX200


The following stocks will be ADDED

  • Brainchip (BRN)

  • Core Lithium (CXO)

  • Lake Resources (LKE) and

  • New Hope Corporation (NHC)

In the ASX200

The following stocks will be REMOVED:

  • Appen (APX)

  • Codan (CDN)

  • Polynovo (PNV)

  • PTM Platinum Asset Management (PTM)

  • Tyro Payments (TYR).


In the ASX Technology Index

The following will be REMOVED:

  • Adore Beauty Group (ABY)

  • Advanced Human Imaging (AHI)

  • Catapult Group (CAT)

  • International Limited (DW8)

  • Envirosuite (EVS)

  • Hipages Group Holdings (HPG)

  • Spenda (SPX)

  • Symbio Holdings (SYM)

  • Volpara Health Technologies (VHT)

  • Vection Technologies (VR1)

And lastly, as we previously alluded to in our story on how to pick stocks, don’t forget you can stay abreast of index rebalances by following news on your favourite indices here.


For daily commentary, follow our global teams insights here. 



Disclaimer

Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at https://www.home.saxo/en-au/legal/.

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Please read our disclaimers:
- Full Disclaimer (https://www.home.saxo/en-au/legal/disclaimer/saxo-disclaimer)
- Analysis Disclaimer (https://www.home.saxo/en-au/legal/analysis-disclaimer/saxo-analysis-disclaimer)
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000
Australia

Contact Saxo

Select region

Australia
Australia

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-au/about-us/awards

Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide, Product Disclosure Statement and Target Market Determination to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation. The Target Market Determination should assist you in determining whether any of the products or services we offer are likely to be consistent with your objectives, financial situation and needs.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.

Please click here to view our full disclaimer.